Publication | Open Access

Long-Term Response to Gefitinib and Crizotinib in Lung Adenocarcinoma Harboring Both Epidermal Growth Factor Receptor Mutation and <i>EML4-ALK</i> Fusion Gene

Tumor BiologyMedicineCancer GrowthCancer Cell BiologyEpithelial-mesenchymal InteractionsCancer BiologyCell BiologyCancer GeneticsOncologyRadiation OncologyCancer ResearchLung CancerMolecular OncologyLong-term Response